Metolazone
Product Images NDC 65580-643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metolazone (NDC 65580-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upstate Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (2½ mg Bottle Label)
This is a warning about not interchanging different drug formulations of metolazone mlflm USP or Zoroxolyn® as well as the Mykrox® formulations. The package circular should be referred to for indications and dosage information. The storage temperature should be kept between 15°C-30°C and light should be avoided. The product contains 100 tablets and is manufactured by UPSTATE in Rochester, NY.*
Principal Display Panel (5 mg Bottle Label)
This appears to be a medication label with dosage instructions and warnings for a product similar to Upstate's Mechuzone Fabes USP and Metolazone Tablets USP. The label specifies that formulations equivalent to Taroxolyn and Mykrox should not be interchanged. It also provides the recommended storage temperature and advises to protect the medication from light and keep it out of reach of children.*
Principal Display Panel (10 mg Bottle Label)
This is information about Metolazone Tablets, USP manufactured by Upstate. It warns not to interchange formulations of this drug with other brands and provides storage instructions. The package circular contains information about indications and dosage. The product contains 10mg of the drug and comes in a bottle of 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.